Gene Technology

Kuopio Center for Gene and Cell Therapy, Kuopio, Finland

Biography

Dr Hanna P. Lesch has played a dual role as research and development director at FinVector Vision Therapies and sister company FKD Therapies since 2013. With more than 15 years of experience in the field of Gene Therapy and vector development, she began her career developing preclinical Gene Therapy approaches and scalable viral vector processes.

Publications

• Short Communication   
  Pricing Pressure of Advanced Therapy Medicinal Products can be Diminished by Contemporary Manufacturing Process Development
  Author(s): Hanna P. Lesch*
  
  The manufacturing of Advanced Therapy Medicinal Products (ATMPs) is still very expensive. Thus, the price tag of the therapy is high. When all the manufacturing steps are optimized, we have possibility to bring costs down. Scalable and cost effective manufacturing process should be defined as early as possible in the product life cycle. Today technology solutions are providing all the tools for process development and optimal process but more work needs to be done before we reach the goal. .. View more»
  

  DOI: 10.35248/2329-6682.21.10.159

  Abstract HTML PDF